Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study
Gunnar Juliusson, Martin Höglund, Karin Karlsson, Christina Löfgren, Lars Möllgård, Christer Paul, Ulf Tidefelt, Magnus Björkholm, for the Leukemia Group of Middle SwedenVolume:
123
Année:
2003
Langue:
english
Pages:
9
DOI:
10.1046/j.1365-2141.2003.04702.x
Fichier:
PDF, 290 KB
english, 2003